Part 3/10:
Furthermore, the speaker highlighted a desire to see meaningful drugs reach the market more rapidly. Currently, the process to approve new medications can take 10 to 12 years, a timeline seen by many experts as excessively long and inefficient, especially when urgent health issues are involved. To address this, the administration is challenging the existing timeline and launching a new program to expedite decisions, aiming for outcomes within weeks rather than years. This approach intends to streamline the pipeline and accelerate the delivery of powerful cures.